China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany
· Delayed Price · Currency is EUR 0.915
0.00 (0.00%)
At close: Dec 5, 2025
FRA:C1S Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 708 | 906 | 636 | 688 | 587 | 422 | Upgrade
|
| Market Cap Growth | -7.34% | 42.53% | -7.56% | 17.23% | 38.92% | -35.30% | Upgrade
|
| Enterprise Value | -93 | 120 | 3 | 64 | 25 | 21 | Upgrade
|
| Last Close Price | 0.92 | 1.09 | 0.71 | 0.74 | 0.52 | 0.39 | Upgrade
|
| PE Ratio | 7.19 | 8.15 | 5.14 | 7.02 | 7.62 | 11.44 | Upgrade
|
| PS Ratio | 1.78 | 1.81 | 1.10 | 1.28 | 1.32 | 1.27 | Upgrade
|
| PB Ratio | 0.76 | 0.92 | 0.71 | 0.80 | 0.72 | 0.58 | Upgrade
|
| P/TBV Ratio | 0.78 | 0.94 | 0.73 | 0.82 | 0.75 | 0.60 | Upgrade
|
| P/FCF Ratio | 7.46 | 8.32 | 6.32 | 5.17 | 6.96 | 5.89 | Upgrade
|
| P/OCF Ratio | 6.17 | 7.11 | 5.35 | 4.57 | 6.03 | 5.28 | Upgrade
|
| EV/Sales Ratio | - | 0.24 | 0.01 | 0.12 | 0.06 | 0.06 | Upgrade
|
| EV/EBITDA Ratio | - | 1.02 | 0.02 | 0.54 | 0.26 | 0.27 | Upgrade
|
| EV/EBIT Ratio | - | 1.09 | 0.02 | 0.67 | 0.34 | 0.40 | Upgrade
|
| EV/FCF Ratio | -0.98 | 1.10 | 0.03 | 0.48 | 0.30 | 0.29 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.05 | 0.04 | 0.00 | 0.00 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.48 | 0.38 | 0.29 | 0.01 | 0.02 | 0.62 | Upgrade
|
| Debt / FCF Ratio | 0.43 | 0.42 | 0.38 | 0.01 | 0.02 | 0.69 | Upgrade
|
| Asset Turnover | 0.33 | 0.39 | 0.51 | 0.51 | 0.45 | 0.37 | Upgrade
|
| Inventory Turnover | 1.15 | 1.11 | 1.44 | 1.63 | 1.58 | 1.53 | Upgrade
|
| Quick Ratio | 3.36 | 3.17 | 2.97 | 3.66 | 4.62 | 3.96 | Upgrade
|
| Current Ratio | 3.69 | 3.51 | 3.35 | 4.07 | 5.19 | 4.62 | Upgrade
|
| Return on Equity (ROE) | 10.94% | 11.59% | 14.45% | 11.77% | 9.52% | 5.10% | Upgrade
|
| Return on Assets (ROA) | 3.98% | 5.33% | 6.81% | 5.78% | 4.63% | 3.68% | Upgrade
|
| Return on Capital (ROIC) | 5.10% | 6.90% | 8.83% | 7.25% | 5.52% | 4.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.10% | 11.00% | 13.60% | 10.90% | 8.80% | 7.00% | Upgrade
|
| Earnings Yield | 13.90% | 12.26% | 19.45% | 14.25% | 13.13% | 8.74% | Upgrade
|
| FCF Yield | 13.41% | 12.02% | 15.81% | 19.33% | 14.37% | 16.97% | Upgrade
|
| Dividend Yield | 6.06% | 6.59% | 7.55% | 5.88% | 10.33% | 10.38% | Upgrade
|
| Payout Ratio | 42.87% | 48.56% | 32.73% | 33.45% | 81.39% | 58.83% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | -0.03% | 0.21% | 3.10% | Upgrade
|
| Total Shareholder Return | 6.06% | 6.59% | 7.55% | 5.85% | 10.54% | 13.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.